Iron deficiency anemia in patients with inflammatory bowel disease

Clinical and Experimental Gastroenterology

Volumn 6, Issue 1, 2013, Pages 61-70

  Goldberg, Neil D ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Anemia; Inflammatory bowel disease; Intravenous iron; Iron deficiency; Oral iron; Therapy

Indexed keywords

FER GEN SOL; FER IRON; FERRETTS; FERRIC CARBOXYMALTOSE; FERRIC GLUCONATE; FERRO SEQUELS; FERROUS FUMARATE; FERROUS GLUCONATE; FERROUS SULFATE; FERUMOXYTOL; IRON; IRON DEXTRAN; IRON SACCHARATE; NEPHRO FER; UNCLASSIFIED DRUG;

ABDOMINAL PAIN; ABNORMAL FECES; CONSTIPATION; DIAGNOSTIC TEST; DIARRHEA; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG INDICATION; DRUG SAFETY; DRUG WITHDRAWAL; ENTERITIS; GASTROINTESTINAL SYMPTOM; HUMAN; IRON DEFICIENCY ANEMIA; IRON THERAPY; MANAGED CARE; NAUSEA; REVIEW; SINGLE DRUG DOSE; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT; VOMITING;

EID: 84878747813     PISSN: None     EISSN: 11787023     Source Type: Journal    
DOI: 10.2147/CEG.S43493     Document Type: Review

References (61)

1. World Health Organization. Worldwide Prevalence of Anaemia 1993-2005: WHO Global Database on Anaemia. Geneva: World Health Organization; 2008.
2. Looker AC, Dallman PR, Carroll MD, Gunter EW, Johnson CL. Prevalence of iron deficiency in the United States. JAMA. 1997;277(12):973-976.
3. Bayraktar UD, Bayraktar S. Treatment of iron deficiency anemia associated with gastrointestinal tract diseases. World J Gastroenterol. 2010;16(22):2720-2725.
4. Bermejo F, García-López S. A guide to diagnosis of iron deficiency and iron deficiency anemia in digestive diseases. World J Gastroenterol. 2009;15(37):4638-4643.
5. Guidelines and Protocols Advisory Committee on behalf of the Medical Services Commission, British Columbia Medical Association. Iron Deficiency-Investigation and Management. 2010 [updated June 15, 2010]. Available from: http://www.bcguidelines.ca/pdf/iron_deficiency.pdf. Accessed April 26, 2012.
6. McIntyre AS, Long RG. Prospective survey of investigations in outpatients referred with iron deficiency anaemia. Gut. 1993;34(8):1102-1107.
7. Stein J, Hartmann F, Dignass AU. Diagnosis and management of iron deficiency anemia in patients with IBD. Nat Rev Gastroenterol Hepatol. 2010;7(11):599-610.
8. Wrighting DM, Andrews NC. Interleukin-6 induces hepcidin expression through STAT3. Blood. 2006;108(9):3204-3209.
9. Pizzi LT, Weston CM, Goldfarb NI, et al. Impact of chronic conditions on quality of life in patients with inflammatory bowel disease. Inflamm Bowel Dis. 2006;12(1):47-52.
10. Wells CW, Lewis S, Barton JR, Corbett S. Effects of changes in hemoglobin level on quality of life and cognitive function in inflammatory bowel disease patients. Inflamm Bowel Dis. 2006;12(2):123-130.
11. Okonko DO, Mandal AK, Missouris CG, Poole-Wilson PA. Disordered iron homeostasis in chronic heart failure: prevalence, predictors, and relation to anemia, exercise capacity, and survival. J Am Coll Cardiol. 2011;58(12):1241-1251.
12. Killip S, Bennett JM, Chambers MD. Iron deficiency anemia. Am Fam Physician. 2007;75(5):671-678.
13. Rockey DC, Cello JP. Evaluation of the gastrointestinal tract in patients with iron-deficiency anemia. N Engl J Med. 1993;329(23):1691-1695.
14. Triester SL, Leighton JA, Leontiadis GI, et al. A meta-analysis of the yield of capsule endoscopy compared to other diagnostic modalities in patients with non-stricturing small bowel Crohn's disease. Am J Gastroenterol. 2006;101(5):954-964.
15. Gasche C, Berstad A, Befrits R, et al. Guidelines on the diagnosis and management of iron deficiency and anemia in inflammatory bowel diseases. Inflamm Bowel Dis. 2007;13(12):1545-1553.
16. Johnson-Wimbley TD, Graham DY. Diagnosis and management of iron deficiency anemia in the 21st century. Therap Adv Gastroenterol. 2011;4(3):177-184.
17. World Health Organization. Iron Deficiency Anaemia: Assessment, Prevention and Control: A Guide for Programme Managers. Geneva: World Health Organization; 2001.
18. Favier A, Ruffieux D. Physiological variations of serum levels of copper, zinc, iron and manganese. Biomed Pharmacother. 1983;37(9-10):462-466.
19. Cook JD, Baynes RD, Skikne BS. Iron deficiency and the measurement of iron status. Nutr Res Rev. 1992;5(1):198-202.
20. Guyatt GH, Oxman AD, Ali M, Willan A, McIlroy W, Patterson C. Laboratory diagnosis of iron-deficiency anemia: an overview. J Gen Intern Med. 1992;7(2):145-153.
21. Bartels U, Pedersen NS, Jarnum S. Iron absorption and serum ferritin in chronic inflammatory bowel disease. Scand J Gastroenterol. 1978;13(6):649-656.
22. Geerts I, Vermeersch P, Joosten E. Evaluation of the first commercial hepcidin ELISA for the differential diagnosis of anemia of chronic disease and iron deficiency anemia in hospitalized geriatric patients. ISRN Hematol. 2012;2012:567491.
23. Vermeulen E, Vermeersch P. Hepcidin as a biomarker for the diagnosis of iron metabolism disorders: a review. Acta Clin Belg. 2012;67(3):190-197.
24. Cucino C, Sonnenberg A. Cause of death in patients with inflammatory bowel disease. Inflamm Bowel Dis. 2001;7(3):250-255.
25. Liu K, Kaffes AJ. Iron deficiency anaemia: a review of diagnosis, investigation and management. Eur J Gastroenterol Hepatol. 2012;24(2):109-116.
26. Goddard AF, James MW, McIntyre AS, Scott BB; for British Society of Gastroenterology. Guidelines for the management of iron deficiency anaemia. Gut. 2011;60(10):1309-1316.
27. Makrides M, Crowther CA, Gibson RA, Gibson RS, Skeaff CM. Efficacy and tolerability of low-dose iron supplements during pregnancy: a randomized controlled trial. Am J Clin Nutr. 2003;78(1):145-153.
28. Rimon E, Kagansky N, Kagansky M, et al. Are we giving too much iron? Low-dose iron therapy is effective in octogenarians. Am J Med. 2005;118(10):1142-1147.
29. National Institutes of Health. Office of Dietary Supplements. Dietary Supplement Fact Sheet: Iron. Bethesda, MD: National Institutes of Health; 2007. Available from: http://ods.od.nih.gov/pdf/factsheets/Iron-HealthProfessional.pdf. Accessed May 3, 2012.
30. Recommendations to prevent and control iron deficiency in the United States. Centers for Disease Control and Prevention. MMWR Recomm Rep. 1998;47(RR-3):1-29.
31. de Silva AD, Tsironi E, Feakins RM, Rampton DS. Efficacy and tolerability of oral iron therapy in inflammatory bowel disease: a prospective, comparative trial. Aliment Pharmacol Ther. 2005;22(11-12): 1097-1105.
32. Kulnigg S, Gasche C. Systematic review: managing anaemia in Crohn's disease. Aliment Pharmacol Ther. 2006;24(11-12):1507-1523.
33. Dostal A, Chassard C, Hilty FM, et al. Iron depletion and repletion with ferrous sulfate or electrolytic iron modifies the composition and metabolic activity of the gut microbiota in rats. J Nutr. 2012;142(2): 271-277.
34. AstraZeneca Pharmaceuticals LP. Prilosec (Omeprazole) Delayed-Release Capsules and Prilosec (Omeprazole Magnesium) for Delayed-Release Oral Suspension. Wilmington, DE: AstraZenca Pharmaceuticals LP; 2012. Available from: http://www1.astrazeneca-us.com/pi/Prilosec.pdf. Accessed April 26, 2012.
35. Disler PB, Lynch SR, Charlton RW, et al. The effect of tea on iron absorption. Gut. 1975;16(3):193-200.
36. Hallberg L, Rossander L, Skånberg AB. Phytates and the inhibitory effect of bran on iron absorption in man. Am J Clin Nutr. 1987;45(5): 988-996.
37. Danielson BG. Structure, chemistry, and pharmacokinetics of intravenous iron agents. J Am Soc Nephrol. 2004;15 Suppl 2:S93-S98.
38. American Regent, Inc. DEXFERRUM (iron dextran) injection, solution [webpage on the Internet]. Bethesda, MD: US National Library of Medicine; 2011. Available from: http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?id=51879. Accessed April 26, 2012.
39. Watson Pharma, Inc. INFeD® (iron dextran injection USP) [webpage on the Internet]. Morristown, NJ: Watson Pharma, Inc; 2009. Available from: http://pi.watson.com/data_stream.asp?product_group=1251&p=pi&language=E. Accessed April 26, 2012.
40. American Regent, Inc. VENOFER (Iron Sucrose Injection, USP). Shirley, NY: American Regent, Inc; 2011. Available from: http://www.americanregent.com/documents/41.pdf. Accessed April 26, 2012.
41. Sanofi-Aventis US LLC. FERRLECIT sodium ferric gluconate complex in sucrose injection [webpage on the Internet]. Bridgewater, NJ: 2011. Available from: http://products.sanofi.us/ferrlecit/ferrlecit.html. Accessed April 26, 2012.
42. AMAG Pharmaceuticals, Inc. FERAHEME Ferumoxytol Injection. Lexington, MA: AMAG Pharmaceuticals, Inc; 2009. Available from: http://www.amagpharma.com/documents/feraheme-productinsert.pdf. Accessed April 26, 2012.
43. Auerbach M, Ballard H, Glaspy J. Clinical update: intravenous iron for anaemia. Lancet. 2007;369(9572):1502-1504.
44. Fishbane S, Ungureanu VD, Maesaka JK, Kaupke CJ, Lim V, Wish J. The safety of intravenous iron dextran in hemodialysis patients. Am J Kidney Dis. 1996;28(4):529-534.
45. Schwartz LB. Diagnostic value of tryptase in anaphylaxis and mastocytosis. Immunol Allergy Clin North Am. 2006;26(3): 451-463.
46. Laman CA, Silverstein SB, Rodgers GM. Parenteral iron therapy: a single institution's experience over a 5-year period. J Natl Compr Canc Netw. 2005;3(6):791-795.
47. Auerbach M, Pappadakis JA, Bahrain H, Auerbach SA, Ballard H, Dahl NV. Safety and efficacy of rapidly administered (one hour) one gram of low molecular weight iron dextran (INFeD) for the treatment of iron deficient anemia. Am J Hematol. 2011;86(10):860-862.
48. Rosner MH, Auerbach M. Ferumoxytol for the treatment of iron deficiency. Expert Rev Hematol. 2011;4(4):399-406.
49. Provenzano R, Schiller B, Rao M, Coyne D, Brenner L, Pereira BJ. Ferumoxytol as an intravenous iron replacement therapy in hemodialysis patients. Clin J Am Soc Nephrol. 2009;4(2):386-393.
50. Singh H, Reed J, Noble S, Cangiano JL, Van Wyck DB; United States Iron Sucrose (Venofer) Clinical Trials Group. Effect of intravenous iron sucrose in peritoneal dialysis patients who receive erythropoiesis-stimulating agents for anemia: a randomized, controlled trial. Clin J Am Soc Nephrol. 2006;1(3):475-482.
51. Koutroubakis IE, Oustamanolakis P, Karakoidas C, Mantzaris GJ, Kouroumalis EA. Safety and efficacy of total-dose infusion of low molecular weight iron dextran for iron deficiency anemia in patients with inflammatory bowel disease. Dig Dis Sci. 2010;55(8):2327-2331.
52. Khalil A, Goodhand JR, Wahed M, Yeung J, Ali FR, Rampton DS. Efficacy and tolerability of intravenous iron dextran and oral iron in inflammatory bowel disease: a case-matched study in clinical practice. Eur J Gastroenterol Hepatol. 2011;23(11):1029-1035.
53. Lindgren S, Wikman O, Befrits R, et al. Intravenous iron sucrose is superior to oral iron sulphate for correcting anaemia and restoring iron stores in IBD patients: A randomized, controlled, evaluator-blind, multicentre study. Scand J Gastroenterol. 2009;44(7):838-845.
54. Schröder O, Mickisch O, Seidler U, et al. Intravenous iron sucrose versus oral iron supplementation for the treatment of iron deficiency anemia in patients with inflammatory bowel disease-a randomized, controlled, open-label, multicenter study. Am J Gastroenterol. 2005;100(11): 2503-2509.
55. Evstatiev R, Marteau P, Iqbal T, et al; for FERGI Study Group. FERGIcor, a randomized controlled trial on ferric carboxymaltose for iron deficiency anemia in inflammatory bowel disease. Gastroenterology. 2011;141(3):846-853. e1-e2.
56. Kulnigg S, Stoinov S, Simanenkov V, et al. A novel intravenous iron formulation for treatment of anemia in inflammatory bowel disease: the ferric carboxymaltose (FERINJECT) randomized controlled trial. Am J Gastroenterol. 2008;103(5):1182-1192.
57. Ganzoni AM. Intravenous iron-dextran: therapeutic and experimental possibilities. Schweiz Med Wochenschr. 1970;100(7):301-303. German.
58. Kulnigg S, Teischinger L, Dejaco C, Waldhör T, Gasche C. Rapid recurrence of IBD-associated anemia and iron deficiency after intravenous iron sucrose and erythropoietin treatment. Am J Gastroenterol. 2009;104(6):1460-1467.
59. Cook JD, Flowers CH, Skikne BS. The quantitative assessment of body iron. Blood. 2003;101(9):3359-3364.
60. Patterson C, Guyatt GH, Singer J, Ali M, Turpie I. Iron deficiency anemia in the elderly: the diagnostic process. CMAJ. 1991;144(4):435-440.
61. Rizvi S, Schoen RE. Supplementation with oral vs intravenous iron for anemia with IBD or gastrointestinal bleeding: is oral iron getting a bad rap? Am J Gastroenterol. 2011;106(11):1872-1879.